<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="cmt-4a" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">cmt-4a</book-part-id>
      <title-group>
        <title><italic toggle="yes">GDAP1</italic>-Related Hereditary Motor and Sensory Neuropathy</title>
        <alt-title alt-title-type="alt-title">Synonyms: <italic toggle="yes">GDAP1</italic>-HMSN, <italic toggle="yes">GDAP1</italic>-Related Charcot-Marie-Tooth Neuropathy</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bird</surname>
            <given-names>Thomas D</given-names>
          </name>
          <degrees>MD</degrees>
          <xref ref-type="aff" rid="cmt-4a.Tc.aff1"/>
          <xref ref-type="aff" rid="cmt-4a.Tc.aff2"/>
          <email>tomnroz@u.washington.edu</email>
        </contrib>
      </contrib-group>
      <aff id="cmt-4a.Tc.aff1">Seattle VA Medical Center</aff>
      <aff id="cmt-4a.Tc.aff2">Departments of Neurology and Medicine <break/>University of Washington<break/>Seattle, Washington</aff>
      <pub-history>
        <date date-type="created">
          <day>11</day>
          <month>5</month>
          <year>2004</year>
        </date>
        <date date-type="updated">
          <day>30</day>
          <month>3</month>
          <year>2017</year>
        </date>
        <date date-type="revised">
          <day>6</day>
          <month>3</month>
          <year>2007</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="gata1" document-type="chapter"><italic toggle="yes">GATA1</italic>-Related X-Linked Cytopenia</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="gm1-ganglio" document-type="chapter"><italic toggle="yes">GLB1-</italic>Related Disorders</related-object>
      <abstract id="cmt-4a.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p><italic toggle="yes">GDAP1</italic>-related hereditary motor and sensory neuropathy (<italic toggle="yes">GDAP1</italic>-HMSN) is a peripheral neuropathy (also known as a subtype of Charcot-Marie-Tooth disease) that typically affects the lower extremities earlier and more severely than the upper extremities. As the neuropathy progresses, the distal upper extremities also become severely affected. Proximal muscles can also become weak. Age at onset ranges from infancy to early childhood. In most cases, disease progression causes disabilities within the first or second decade of life. At the end of the second decade, most individuals are wheelchair bound. Disease progression varies considerably even within the same family. The neuropathy can be either of the demyelinating type with reduced nerve conduction velocities or the axonal type with normal nerve conduction velocities. Vocal cord paresis is common. Intelligence is normal. Life expectancy is usually normal, but on occasion may be reduced because of secondary complications.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Diagnosis of <italic toggle="yes">GDAP1</italic>-HMSN is based on clinical findings and confirmed by detection on molecular genetic testing of either biallelic pathogenic variants in <italic toggle="yes">GDAP1</italic> in those with autosomal recessive inheritance or a heterozygous pathogenic variant in those with autosomal dominant inheritance.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Treatment is symptomatic and involves evaluation and management by a multidisciplinary team that includes neurologists, physiatrists, orthopedic surgeons, and physical and occupational therapists. Treatment may include: daily heel cord stretching exercises to prevent Achilles tendon shortening, ankle/foot orthoses, orthopedic surgery, forearm crutches or canes, wheelchairs, treatment of musculoskeletal pain with acetaminophen or nonsteroidal anti-inflammatory agents, and career and employment counseling.</p>
          <p><italic toggle="yes">Surveillance</italic>: Regular evaluation by the multidisciplinary team to determine neurologic status and functional disability.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Drugs and medications known to cause nerve damage; obesity.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">GDAP1</italic>-HMSN is usually inherited in an autosomal recessive (AR) manner; autosomal dominant (AD) inheritance is also observed.</p>
          <list list-type="bullet">
            <list-item>
              <p><italic toggle="yes">AR inheritance:</italic> At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being an asymptomatic carrier, and a 25% chance of being unaffected and not a carrier. Carrier testing for at-risk relatives is possible once the pathogenic variants in an affected family member have been identified.</p>
            </list-item>
            <list-item>
              <p><italic toggle="yes">AD inheritance:</italic> Offspring of an individual with AD <italic toggle="yes">GDAP1</italic>-HMSN have a 50% risk of inheriting the <italic toggle="yes">GDAP1</italic> pathogenic variant from their affected parent.</p>
            </list-item>
          </list>
          <p>Prenatal testing for pregnancies at increased risk for <italic toggle="yes">GDAP1</italic>-HMSN and preimplantation genetic diagnosis are possible for families in which the pathogenic variant(s) have been identified.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="cmt-4a.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="cmt-4a.Td" orientation="portrait" position="anchor">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_cmt-4a.Td_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_cmt-4a.Td_1_1_1_1"><italic toggle="yes">GDAP1</italic>-Related Hereditary Motor and Sensory Neuropathy Subtype</th>
                <th id="hd_h_cmt-4a.Td_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_cmt-4a.Td_1_1_1_2">MOI</th>
                <th id="hd_h_cmt-4a.Td_1_1_1_3" valign="middle" colspan="3" align="left" scope="colgroup" rowspan="1">Neuropathy Type</th>
              </tr>
              <tr>
                <th headers="hd_h_cmt-4a.Td_1_1_1_3" id="hd_h_cmt-4a.Td_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Demyelinating</th>
                <th headers="hd_h_cmt-4a.Td_1_1_1_3" id="hd_h_cmt-4a.Td_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Axonal</th>
                <th headers="hd_h_cmt-4a.Td_1_1_1_3" id="hd_h_cmt-4a.Td_1_1_2_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Intermediate</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_cmt-4a.Td_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">CMT4A</td>
                <td headers="hd_h_cmt-4a.Td_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_cmt-4a.Td_1_1_1_3 hd_h_cmt-4a.Td_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                <td headers="hd_h_cmt-4a.Td_1_1_1_3 hd_h_cmt-4a.Td_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                <td headers="hd_h_cmt-4a.Td_1_1_1_3 hd_h_cmt-4a.Td_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td headers="hd_h_cmt-4a.Td_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">CMT2H</td>
                <td headers="hd_h_cmt-4a.Td_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_cmt-4a.Td_1_1_1_3 hd_h_cmt-4a.Td_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                <td headers="hd_h_cmt-4a.Td_1_1_1_3 hd_h_cmt-4a.Td_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                <td headers="hd_h_cmt-4a.Td_1_1_1_3 hd_h_cmt-4a.Td_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
              </tr>
              <tr>
                <td headers="hd_h_cmt-4a.Td_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">CMTRIA</td>
                <td headers="hd_h_cmt-4a.Td_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">AR</td>
                <td headers="hd_h_cmt-4a.Td_1_1_1_3 hd_h_cmt-4a.Td_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                <td headers="hd_h_cmt-4a.Td_1_1_1_3 hd_h_cmt-4a.Td_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1"/>
                <td headers="hd_h_cmt-4a.Td_1_1_1_3 hd_h_cmt-4a.Td_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1">X</td>
              </tr>
              <tr>
                <td headers="hd_h_cmt-4a.Td_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">CMT2K</td>
                <td headers="hd_h_cmt-4a.Td_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">AD</td>
                <td headers="hd_h_cmt-4a.Td_1_1_1_3 hd_h_cmt-4a.Td_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1"/>
                <td headers="hd_h_cmt-4a.Td_1_1_1_3 hd_h_cmt-4a.Td_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">X</td>
                <td headers="hd_h_cmt-4a.Td_1_1_1_3 hd_h_cmt-4a.Td_1_1_2_3" valign="middle" align="left" rowspan="1" colspan="1"/>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>MOI = mode of inheritance</p>
            </fn>
            <fn>
              <p>AD = autosomal dominant</p>
            </fn>
            <fn>
              <p>AR = autosomal recessive</p>
            </fn>
            <fn>
              <p>CMT = Charcot-Marie-Tooth neuropathy</p>
            </fn>
            <fn>
              <p>CMTRIA = Charcot-Marie-Tooth Neuropathy, recessive intermediate A</p>
            </fn>
            <fn>
              <p>Hereditary motor and sensory neuropathy is also referred to as &#x0201c;Charcot-Marie-Tooth neuropathy&#x0201d;; see <xref ref-type="sec" rid="cmt-4a.Nomenclature">Nomenclature</xref> for further discussion of term usage.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="cmt-4a.Diagnosis">
        <title>Diagnosis</title>
        <sec id="cmt-4a.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p><italic toggle="yes">GDAP1</italic>-related hereditary motor and sensory neuropathy (<italic toggle="yes">GDAP1</italic>-HMSN) <bold>should be suspected</bold> in individuals with the following clinical and nerve conduction velocity findings.</p>
          <p>
            <bold>Clinical findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Early onset of peripheral neuropathy, presenting especially with foot deformities, muscle wasting, and involvement of the sensory nerves resulting in decreased appreciation of touch, pain, and vibration. Proximal weakness usually comes later.</p>
            </list-item>
            <list-item>
              <p>Disability within the first and second decade of life consisting of foot deformity, difficulty walking and claw hand deformity.</p>
            </list-item>
            <list-item>
              <p>Vocal cord paresis manifest as a hoarse voice</p>
            </list-item>
            <list-item>
              <p>Mild to moderate scoliosis</p>
            </list-item>
            <list-item>
              <p>Occasional involvement of cranial nerves sometimes resulting in facial weakness.</p>
            </list-item>
          </list>
          <p>
            <bold>Nerve conduction velocities (NCVs)</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>
                <bold>Motor NCVs</bold>
              </p>
              <list list-type="bullet">
                <list-item>
                  <p>Most commonly are consistent with an axonal neuropathy with normal NCVs and reduced amplitudes [<xref ref-type="bibr" rid="cmt-4a.REF.sevilla.2003.2023">Sevilla et al 2003</xref>].</p>
                </list-item>
                <list-item>
                  <p>Occasionally are consistent with either a demyelinating neuropathy with slowed NCVs (less than 38m/s) [<xref ref-type="bibr" rid="cmt-4a.REF.baxter.2002.21">Baxter et al 2002</xref>, <xref ref-type="bibr" rid="cmt-4a.REF.nelis.2002.1865">Nelis et al 2002</xref>, <xref ref-type="bibr" rid="cmt-4a.REF.ammar.2003.720">Ammar et al 2003</xref>, <xref ref-type="bibr" rid="cmt-4a.REF.de_sandregiovannoli.2003.e87">De Sandre-Giovannoli et al 2003</xref>] or an intermediate range (30-40m/s) [<xref ref-type="bibr" rid="cmt-4a.REF.senderek.2003.642">Senderek et al 2003</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Sensory NCVs</bold> are moderately reduced.</p>
            </list-item>
          </list>
        </sec>
        <sec id="cmt-4a.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of HMSN <bold>is established</bold> in a proband with typical clinical findings; the diagnosis of <italic toggle="yes">GDAP1</italic>-HMSN is established by the detection of either biallelic <italic toggle="yes">GDAP1</italic> pathogenic variants (in those with autosomal recessive inheritance) or a heterozygous <italic toggle="yes">GDAP1</italic> pathogenic variant pathogenic variant (in those with autosomal dominant inheritance) (see <xref ref-type="table" rid="cmt-4a.T.molecular_genetic_testing_used">Table 1</xref>) on molecular genetic testing.</p>
          <p>Molecular genetic testing approaches can include a combination of <bold>gene-targeted testing</bold> (single-gene testing or a multi-gene panel) and <bold>genomic testing</bold> (comprehensive genome sequencing) depending on the phenotype.</p>
          <p>Gene-targeted testing requires that the clinician determine which gene(s) are likely involved, whereas genomic testing does not. Because the phenotype of <italic toggle="yes">GDAP1</italic>-HMSN is broad, individuals with the distinctive findings described in <xref ref-type="sec" rid="cmt-4a.Suggestive_Findings">Suggestive Findings</xref> may be diagnosed using gene-targeted testing (see <xref ref-type="sec" rid="cmt-4a.Option_1">Option 1</xref>), whereas those with a phenotype indistinguishable from many other hereditary motor and sensory neuropathies are more likely to be diagnosed using genomic testing (see <xref ref-type="sec" rid="cmt-4a.Option_2">Option 2</xref>).</p>
          <sec id="cmt-4a.Option_1">
            <title>Option 1</title>
            <p>When the phenotypic and laboratory findings suggest the diagnosis of <italic toggle="yes">GDAP1</italic>-HMSN, molecular genetic testing approaches can include <bold>single-gene testing</bold> or use of a hereditary motor and sensory neuropathy (Charcot-Marie-Tooth disease) <bold>multi-gene panel</bold>.</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">GDAP1</italic> is performed first. If only one pathogenic variant is found, gene-targeted deletion/duplication analysis can be considered; however, to date no exon or whole-gene deletions have been reported.</p>
              </list-item>
              <list-item>
                <p><bold>A hereditary motor and sensory neuropathy (Charcot-Marie-Tooth disease) multi-gene panel</bold> that includes <italic toggle="yes">GDAP1</italic> and other genes of interest (see <related-object link-type="booklink" source-id="gene" document-id="cmt" document-type="chapter">Charcot-Marie-Tooth Hereditary Neuropathy Overview</related-object> and <xref ref-type="sec" rid="cmt-4a.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time. (2) Some HMSN (CMT) multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of condition at the most reasonable cost while limiting secondary findings. Of note, given the rarity of <italic toggle="yes">GDAP1</italic>-HMSN many panels for HMSN may not include this gene.</p>
                <p>For more information on multi-gene panels click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.MultiGene_Panels" object-type="sec">here</related-object>.</p>
              </list-item>
            </list>
          </sec>
          <sec id="cmt-4a.Option_2">
            <title>Option 2</title>
            <p>When the phenotype is indistinguishable from many other hereditary motor and sensory neuropathies, molecular genetic testing approaches can include <bold>genomic testing</bold> (comprehensive genome sequencing) and/or <bold>gene-targeted testing</bold> (multi-gene panel).</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Comprehensive genome sequencing</bold> (when clinically available) includes exome sequencing and genome sequencing. For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
              </list-item>
              <list-item>
                <p><bold>A hereditary motor and sensory neuropathy (Charcot-Marie-Tooth disease) multi-gene panel</bold> may also be consdered.</p>
              </list-item>
            </list>
            <table-wrap id="cmt-4a.T.molecular_genetic_testing_used" orientation="portrait" position="anchor">
              <label>Table 1. </label>
              <caption>
                <p>Molecular Genetic Testing Used in <italic toggle="yes">GDAP1</italic>-Related Hereditary Motor and Sensory Neuropathy</p>
              </caption>
              <table frame="hsides" rules="groups">
                <thead>
                  <tr>
                    <th id="hd_h_cmt-4a.T.molecular_genetic_testing_used_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                    <th id="hd_h_cmt-4a.T.molecular_genetic_testing_used_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                    <th id="hd_h_cmt-4a.T.molecular_genetic_testing_used_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with Pathogenic Variants&#x000a0;<sup>2</sup> Detectable by This Method</th>
                  </tr>
                </thead>
                <tbody>
                  <tr>
                    <td headers="hd_h_cmt-4a.T.molecular_genetic_testing_used_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                      <italic toggle="yes">GDAP1</italic>
                    </td>
                    <td headers="hd_h_cmt-4a.T.molecular_genetic_testing_used_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                    <td headers="hd_h_cmt-4a.T.molecular_genetic_testing_used_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">~100%&#x000a0;<sup>4</sup></td>
                  </tr>
                  <tr>
                    <td headers="hd_h_cmt-4a.T.molecular_genetic_testing_used_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>5</sup></td>
                    <td headers="hd_h_cmt-4a.T.molecular_genetic_testing_used_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>4</sup></td>
                  </tr>
                </tbody>
              </table>
              <table-wrap-foot>
                <fn id="cmt-4a.TF.1.1">
                  <label>1. </label>
                  <p>See <related-object source-id="gene" document-id="cmt-4a" object-id="cmt-4a.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
                </fn>
                <fn id="cmt-4a.TF.1.2">
                  <label>2. </label>
                  <p>See <xref ref-type="sec" rid="cmt-4a.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
                </fn>
                <fn id="cmt-4a.TF.1.3">
                  <label>3. </label>
                  <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
                </fn>
                <fn id="cmt-4a.TF.1.4">
                  <label>4. </label>
                  <p>Pathogenic variants in <italic toggle="yes">GDAP1</italic> are identified in nearly 100% of individuals with autosomal recessive CMT whose disease has been mapped to 8q13-q21.1 [<xref ref-type="bibr" rid="cmt-4a.REF.manganelli.2014.292">Manganelli et al 2014</xref>].</p>
                </fn>
                <fn id="cmt-4a.TF.1.5">
                  <label>5. </label>
                  <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
                </fn>
                <fn id="cmt-4a.TF.1.6">
                  <label>6. </label>
                  <p>No data on detection rate of gene-targeted deletion/duplication analysis are available.</p>
                </fn>
              </table-wrap-foot>
            </table-wrap>
          </sec>
        </sec>
      </sec>
      <sec id="cmt-4a.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="cmt-4a.Clinical_Description">
          <title>Clinical Description</title>
          <p><italic toggle="yes">GDAP1</italic>-related hereditary motor and sensory neuropathy (<italic toggle="yes">GDAP1</italic>-HMSN) can be inherited in either an autosomal recessive (AR) manner (more common) or an autosomal dominant (AD) manner. The phenotype of AR <italic toggle="yes">GDAP1</italic>-HMSN is more severe than that of AD <italic toggle="yes">GDAP1</italic>-HMSN.</p>
          <table-wrap id="cmt-4a.T.comparison_of_autosomal_recessi" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p>Comparison of Autosomal Recessive and Autosomal Dominant <italic toggle="yes">GDAP1</italic>-Related Hereditary Motor and Sensory Neuropathy</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_cmt-4a.T.comparison_of_autosomal_recessi_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">GDAP1</italic>-HMSN Subtype</th>
                  <th id="hd_h_cmt-4a.T.comparison_of_autosomal_recessi_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Neuropathy Type</th>
                  <th id="hd_h_cmt-4a.T.comparison_of_autosomal_recessi_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Clinical Severity</th>
                  <th id="hd_h_cmt-4a.T.comparison_of_autosomal_recessi_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Age of Onset</th>
                  <th id="hd_h_cmt-4a.T.comparison_of_autosomal_recessi_1_1_1_5" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Vocal Paresis</th>
                  <th id="hd_h_cmt-4a.T.comparison_of_autosomal_recessi_1_1_1_6" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Disease Progression</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_cmt-4a.T.comparison_of_autosomal_recessi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>AR <italic toggle="yes">GDAP1</italic>-HMSN (CMT4A, CMT2H, &#x00026; CMTRIA)</bold>
                  </td>
                  <td headers="hd_h_cmt-4a.T.comparison_of_autosomal_recessi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Typically axonal; demyelinating &#x00026; intermediate also observed</td>
                  <td headers="hd_h_cmt-4a.T.comparison_of_autosomal_recessi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Aggressive</td>
                  <td headers="hd_h_cmt-4a.T.comparison_of_autosomal_recessi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Early (onset can be infancy)</td>
                  <td headers="hd_h_cmt-4a.T.comparison_of_autosomal_recessi_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Common</td>
                  <td headers="hd_h_cmt-4a.T.comparison_of_autosomal_recessi_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Most individuals wheelchair bound by end of 2nd decade</td>
                </tr>
                <tr>
                  <td headers="hd_h_cmt-4a.T.comparison_of_autosomal_recessi_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">
                    <bold>AD <italic toggle="yes">GDAP1</italic>-HMSN (CMT2K)</bold>
                  </td>
                  <td headers="hd_h_cmt-4a.T.comparison_of_autosomal_recessi_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Typically axonal or demyelinating; intermediate also observed</td>
                  <td headers="hd_h_cmt-4a.T.comparison_of_autosomal_recessi_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Mild relative to AR CMT</td>
                  <td headers="hd_h_cmt-4a.T.comparison_of_autosomal_recessi_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">Varies from childhood to late adulthood</td>
                  <td headers="hd_h_cmt-4a.T.comparison_of_autosomal_recessi_1_1_1_5" valign="middle" align="left" rowspan="1" colspan="1">Rare</td>
                  <td headers="hd_h_cmt-4a.T.comparison_of_autosomal_recessi_1_1_1_6" valign="middle" align="left" rowspan="1" colspan="1">Slow disease progression</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>CMT = Charcot-Marie-Tooth neuropathy</p>
              </fn>
              <fn>
                <p>CMTRIA = Charcot-Marie-Tooth Neuropathy, recessive intermediate A</p>
              </fn>
              <fn>
                <p>HMSN = hereditary motor and sensory neuropathy; also referred to as &#x0201c;Charcot-Marie-Tooth neuropathy.&#x0201d; See <xref ref-type="sec" rid="cmt-4a.Nomenclature">Nomenclature</xref> for further discussion of term usage.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <sec id="cmt-4a.Autosomal_Recessive_AR_GDAP1HMSN">
            <title>Autosomal Recessive (AR) <italic toggle="yes">GDAP1</italic>-HMSN</title>
            <p><bold>AR <italic toggle="yes">GDAP1</italic>-HMSN</bold> is an aggressive severe form with early onset and unusual manifestations. The disease is confined to the peripheral nervous system. Intellect is normal.</p>
            <p>When onset of motor nerve involvement is in utero, affected newborns are hypotonic (i.e., a "floppy infant"). Onset can be in infancy, often before age two years. Affected children can show delayed achievement of motor milestones, including walking.</p>
            <p>Initial manifestations are typically in the distal lower extremities, including the following:</p>
            <list list-type="bullet">
              <list-item>
                <p>Foot deformities (high arch; hammertoe; pes cavus or equinovarus; severe clubfoot deformity [<xref ref-type="bibr" rid="cmt-4a.REF.bouhouche.2007.1062">Bouhouche et al 2007</xref>])</p>
              </list-item>
              <list-item>
                <p>Muscle wasting</p>
              </list-item>
              <list-item>
                <p>Areflexia</p>
              </list-item>
              <list-item>
                <p>Sensory loss</p>
              </list-item>
            </list>
            <p>Most authors describe early involvement of the upper extremities with distal muscle weakness and wasting and finger contractures (claw hands).</p>
            <p>Sensory involvement leads to decreased appreciation in distal upper and lower limbs of touch, pain, vibration, and joint position.</p>
            <p>In the majority of persons with AR <italic toggle="yes">GDAP1</italic>-HMSN nerve conduction velocities (NCVs) (see <xref ref-type="sec" rid="cmt-4a.Suggestive_Findings">Suggestive Findings</xref>) are consistent with an <bold>axonal</bold> neuropathy. However, in a few persons NCVs are consistent with either a <bold>demyelinating</bold> neuropathy or an <bold>intermediate-range</bold> neuropathy. The clinical manifestations are not consistently distinct among these three neuropathy types.</p>
            <p>As the neuropathy progresses the voice becomes hoarse as a result of vocal cord paresis [<xref ref-type="bibr" rid="cmt-4a.REF.sevilla.2003.2023">Sevilla et al 2003</xref>, <xref ref-type="bibr" rid="cmt-4a.REF.stojkovic.2004.261">Stojkovic et al 2004</xref>]. In some series, vocal cord paresis has been reported more often with axonal neuropathy than with demyelinating neuropathy [<xref ref-type="bibr" rid="cmt-4a.REF.cuesta.2002.22">Cuesta et al 2002</xref>], whereas in other series the converse has been observed [<xref ref-type="bibr" rid="cmt-4a.REF.boerkoel.2003.400">Boerkoel et al 2003</xref>].</p>
            <p>Rare manifestations of AR <italic toggle="yes">GDAP1</italic>-related neuropathy include the following:</p>
            <list list-type="bullet">
              <list-item>
                <p>Spinal deformities [<xref ref-type="bibr" rid="cmt-4a.REF.birouk.2003.598">Birouk et al 2003</xref>, <xref ref-type="bibr" rid="cmt-4a.REF.de_sandregiovannoli.2003.e87">De Sandre-Giovannoli et al 2003</xref>, <xref ref-type="bibr" rid="cmt-4a.REF.sevilla.2003.2023">Sevilla et al 2003</xref>]</p>
              </list-item>
              <list-item>
                <p>Facial weakness [<xref ref-type="bibr" rid="cmt-4a.REF.boerkoel.2003.400">Boerkoel et al 2003</xref>]</p>
              </list-item>
              <list-item>
                <p>Painless lower-leg ulcers [<xref ref-type="bibr" rid="cmt-4a.REF.nelis.2002.1865">Nelis et al 2002</xref>]</p>
              </list-item>
            </list>
            <p>Progression of the neuropathy leads to disability of the lower and upper extremities. At the end of the second decade, most individuals are wheelchair bound. Phrenic nerve paresis has sometimes led to restrictive respiratory function [<xref ref-type="bibr" rid="cmt-4a.REF.sevilla.2008.3051">Sevilla et al 2008</xref>]. Life expectancy is usually normal, but on occasion may be reduced because of secondary complications.</p>
            <p>Although persons with AR <italic toggle="yes">GDAP1-HMSN</italic> are usually more severely affected than those with AD inheritance, <xref ref-type="bibr" rid="cmt-4a.REF.kabzi_ska.2010.357">Kabzi&#x00144;ska et al [2010]</xref> reported a founder variant in Europe (p.Leu239Phe) associated with a milder phenotype.</p>
            <p>Intrafamilial variability in disease progression was observed in one family in which the proband was wheelchair bound by age 20 years and his sister remained ambulatory with a crutch at age 26 years [<xref ref-type="bibr" rid="cmt-4a.REF.azzedine.2003.341">Azzedine et al 2003</xref>].</p>
            <p>Heterozygotes in families with AR <italic toggle="yes">GDAP1</italic>-HMSN are usually unaffected; however, exceptions are two families with the p.Glu222Lys pathogenic variant in which some heterozygotes had mild manifestations [<xref ref-type="bibr" rid="cmt-4a.REF.kabzi_ska.2014.739">Kabzi&#x00144;ska et al 2014</xref>].</p>
            <p><bold>Neuropathology.</bold> Both demyelinating and axonal peripheral nerve lesions have been observed. Prominent loss of medium-sized and large myelinated fibers has been described [<xref ref-type="bibr" rid="cmt-4a.REF.nelis.2002.1865">Nelis et al 2002</xref>, <xref ref-type="bibr" rid="cmt-4a.REF.ammar.2003.720">Ammar et al 2003</xref>, <xref ref-type="bibr" rid="cmt-4a.REF.boerkoel.2003.400">Boerkoel et al 2003</xref>, <xref ref-type="bibr" rid="cmt-4a.REF.sevilla.2003.2023">Sevilla et al 2003</xref>]. Onion bulb formations as well as thinly myelinated and unmyelinated axons have been observed [<xref ref-type="bibr" rid="cmt-4a.REF.nelis.2002.1865">Nelis et al 2002</xref>, <xref ref-type="bibr" rid="cmt-4a.REF.de_sandregiovannoli.2003.e87">De Sandre-Giovannoli et al 2003</xref>]. In one study, findings were interpreted as an intermediate type of neuropathy [<xref ref-type="bibr" rid="cmt-4a.REF.senderek.2003.642">Senderek et al 2003</xref>]. Focally folded myelin is not a feature.</p>
          </sec>
          <sec id="cmt-4a.Autosomal_Dominant_AD_GDAP1HMSN">
            <title>Autosomal Dominant (AD) <italic toggle="yes">GDAP1</italic>-HMSN</title>
            <p><bold>AD <italic toggle="yes">GDAP1</italic>-HMSN</bold> &#x02013; compared with AR <italic toggle="yes">GDAP1</italic>-HMSN &#x02013; is typically associated with a milder phenotype that is slowly progressive.</p>
            <p>AD <italic toggle="yes">GDAP1</italic>-HMSN has been reported in the following:</p>
            <list list-type="bullet">
              <list-item>
                <p>Three Spanish families. In two families segregating the variant <xref ref-type="table" rid="cmt-4a.T.selected_gdap1_pathogenic_varia">p.Arg120Trp</xref> and in a third family the variant <xref ref-type="table" rid="cmt-4a.T.selected_gdap1_pathogenic_varia">p.Thr157Pro</xref> occurred <italic toggle="yes">de novo</italic> in the proband (whose paternity was confirmed) [<xref ref-type="bibr" rid="cmt-4a.REF.claramunt.2005.358">Claramunt et al 2005</xref>].</p>
              </list-item>
              <list-item>
                <p>Eight families (in which 3 demonstrated reduced penetrance) with four different missense variants, including three families with the variant <xref ref-type="table" rid="cmt-4a.T.selected_gdap1_pathogenic_varia">p.Arg120Trp</xref> [<xref ref-type="bibr" rid="cmt-4a.REF.zimo_.2011.540">Zimo&#x00144; et al 2011</xref>]</p>
              </list-item>
            </list>
            <p>Onset varies from childhood to late adulthood. Difficulty with walking is the most common initial manifestation. Weakness and atrophy are usually restricted to distal muscles of the upper and lower limbs. Vocal cord paresis and thoracic scoliosis are uncommon. Disease progression is slow; affected persons generally remain ambulatory.</p>
          </sec>
        </sec>
        <sec id="cmt-4a.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>Possible genotype-phenotype correlations have been reported but are not common enough to be confirmed. An exception is the founder variant in eastern Europe, <xref ref-type="table" rid="cmt-4a.T.selected_gdap1_pathogenic_varia">p.Leu239Phe</xref>, which appears to be associated with a comparably milder phenotype [<xref ref-type="bibr" rid="cmt-4a.REF.kabzi_ska.2010.357">Kabzi&#x00144;ska et al 2010</xref>].</p>
          <p>The <italic toggle="yes">GDAP1</italic> pathogenic variant, p.Glu222Lys, may be uniquely associated with both AR <italic toggle="yes">GDAP1</italic>-HMSN and (in rare cases) AD <italic toggle="yes">GDAP1</italic>-HMSN [<xref ref-type="bibr" rid="cmt-4a.REF.kabzi_ska.2014.739">Kabzi&#x00144;ska et al 2014</xref>].</p>
          <p><bold>Co-occurrence of pathogenic variants in genes causing two different types of HMSN.</bold> The co-occurrence of two HMSN-related pathogenic variants presumably resulted in an additive effect and suggests consideration of simultaneous variants in two HMSN-related genes as an explanation in unusual or severe cases:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold><italic toggle="yes">GDAP1</italic> and <italic toggle="yes">MFN2.</italic></bold>
<xref ref-type="bibr" rid="cmt-4a.REF.kosterapruszczyk.2014.242">Kostera-Pruszczyk et al [2014]</xref> reported a child with severe HMSN who was found to be heterozygous for the <italic toggle="yes">GDAP1</italic> pathogenic variant, <xref ref-type="table" rid="cmt-4a.T.selected_gdap1_pathogenic_varia">p.His123Arg</xref>, and the <italic toggle="yes">MFN2</italic> pathogenic variant, p.Thr236Met<italic toggle="yes">.</italic> The co-occurrence of pathogenic variants in these two genes was also reported by <xref ref-type="bibr" rid="cmt-4a.REF.cassereau.2011.1524">Cassereau et al [2011]</xref> and <xref ref-type="bibr" rid="cmt-4a.REF.vital.2012.735">Vital et al [2012]</xref>.</p>
            </list-item>
            <list-item>
              <p><bold><italic toggle="yes">GDAP1</italic> and <italic toggle="yes">PRX</italic>.</bold>
<xref ref-type="bibr" rid="cmt-4a.REF.auergrumbach.2008.33">Auer-Grumbach et al [2008]</xref> reported two novel <italic toggle="yes">GDAP1</italic> and <italic toggle="yes">PRX</italic> variants associated with early-onset HMSN.</p>
            </list-item>
          </list>
        </sec>
        <sec id="cmt-4a.Penetrance">
          <title>Penetrance</title>
          <p>Reduced penetrance has been reported in AD <italic toggle="yes">GDAP1</italic>-HMSN. Several heterozygotes have been reported to be mildly affected or asymptomatic at an advanced age [<xref ref-type="bibr" rid="cmt-4a.REF.zimo_.2011.540">Zimo&#x00144; et al 2011</xref>].</p>
        </sec>
        <sec id="cmt-4a.Nomenclature">
          <title>Nomenclature</title>
          <p>Hereditary motor and sensory neuropathy is most commonly referred to by the eponymous name, &#x0201c;Charcot-Marie-Tooth (CMT) neuropathy&#x0201d; or &#x0201c;Charcot-Marie-Tooth disease.&#x0201d;</p>
          <p>Based on an older classification system in which subtypes were defined by clinical parameters such as mode of inheritance, clinical findings, neuropathy type (defined by electrophysiologic findings), and involved gene, <italic toggle="yes">GDAP1</italic>-related hereditary motor and sensory neuropathy has been referred to in the past as:</p>
          <list list-type="bullet">
            <list-item>
              <p>CMT4A, autosomal recessive, demyelinating HMSN</p>
            </list-item>
            <list-item>
              <p>CMT2H, autosomal recessive, axonal HMSN</p>
            </list-item>
            <list-item>
              <p>CMTRIA, autosomal recessive, intermediate HMSN</p>
            </list-item>
            <list-item>
              <p>CMT2K, autosomal dominant, axonal HMSN</p>
            </list-item>
          </list>
          <p>However, classification using these clinically defined parameters becomes difficult when pathogenic variants in a single gene (e.g., <italic toggle="yes">GDAP1</italic>) are associated with more than one mode of inheritance (e.g., both autosomal dominant and autosomal recessive inheritance), and/or more than one neuropathy type (axonal, demyelinating, and/or intermediate). To disambiguate, the general term <italic toggle="yes">GDAP1</italic>-related hereditary motor and sensory neuropathy (<italic toggle="yes">GDAP1</italic>-HMSN) is used in this <italic toggle="yes">GeneReview</italic>. For further review of nomenclature, see the <related-object link-type="booklink" source-id="gene" document-id="cmt" document-type="chapter">Charcot-Marie-Tooth Hereditary Neuropathy Overview</related-object>.</p>
        </sec>
        <sec id="cmt-4a.Prevalence">
          <title>Prevalence</title>
          <p>Currently, autosomal recessive <italic toggle="yes">GDAP1</italic>-HMSN is considered one of the most common autosomal recessive hereditary neuropathies.</p>
          <p>Molecular genetic testing has shown the following proportion of individuals with HMSN (also known as CMT) with <italic toggle="yes">GDAP1</italic> pathogenic variants:</p>
          <list list-type="bullet">
            <list-item>
              <p>Three of 69 (4.3%) unrelated Czech individuals with autosomal recessive CMT [<xref ref-type="bibr" rid="cmt-4a.REF.bar_nkov_.2007.482">Bar&#x000e1;nkov&#x000e1; et al 2007</xref>]</p>
            </list-item>
            <list-item>
              <p>Eight of 197 (5.4%) individuals in an Italian population with CMT [<xref ref-type="bibr" rid="cmt-4a.REF.manganelli.2014.292">Manganelli et al 2014</xref>]</p>
            </list-item>
            <list-item>
              <p>Five of 174 (2.8%) families from Europe with autosomal recessive CMT screened for thirteen genes known to be associated with AR-HMSN [<xref ref-type="bibr" rid="cmt-4a.REF.zimo_.2015.33">Zimo&#x00144; et al 2015</xref>]</p>
            </list-item>
            <list-item>
              <p>1% of 1000 individuals with an inherited peripheral neuropathy in Japan [<xref ref-type="bibr" rid="cmt-4a.REF.yoshimura.2017">Yoshimura et al 2017</xref>]</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec id="cmt-4a.Genetically_Related_Allelic_Disor">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> have been associated with pathogenic variants in <italic toggle="yes">GDAP1</italic>.</p>
      </sec>
      <sec id="cmt-4a.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p>See <related-object link-type="booklink" source-id="gene" document-id="cmt" document-type="chapter">Charcot-Marie-Tooth Hereditary Neuropathy Overview</related-object> and <related-object link-type="booklink" source-id="gene" document-id="cmt4" document-type="chapter">Charcot-Marie-Tooth Neuropathy Type 4</related-object>.</p>
        <p>Vocal cord paresis, which is often seen in autosomal recessive <italic toggle="yes">GDAP1</italic>-related HMSN, also occurs in other types of CMT, such as <related-object link-type="booklink" source-id="gene" document-id="cmt2c" document-type="chapter"><italic toggle="yes">TRPV4</italic>-related hereditary neuropathy</related-object>.</p>
        <p>While AR <italic toggle="yes">GDAP1</italic>-HMSN is considered one of the most common causes of autosomal recessive CMT, <italic toggle="yes">SH3TC2-</italic>HMSN is equally common in some studies [<xref ref-type="bibr" rid="cmt-4a.REF.rudniksch_neborn.2016.34">Rudnik-Sch&#x000f6;neborn et al 2016</xref>].</p>
      </sec>
      <sec id="cmt-4a.Management">
        <title>Management</title>
        <sec id="cmt-4a.Evaluations_Following_Initial_Dia">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with a <italic toggle="yes">GDAP1</italic>-related hereditary motor and sensory neuropathy (<italic toggle="yes">GDAP1</italic>-HMSN), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic examination to determine extent of weakness and atrophy, pes cavus, gait stability, and sensory loss</p>
            </list-item>
            <list-item>
              <p>Physical therapy and occupational therapy assessments regarding muscle weakness and gait and need for ankle foot orthoses, walking aids, and/or a wheelchair [<xref ref-type="bibr" rid="cmt-4a.REF.kennedy.2016.317">Kennedy et al 2016</xref>]</p>
            </list-item>
            <list-item>
              <p>Speech therapy assessment if hoarseness is present or vocal cord paresis is suspected</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="cmt-4a.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Individuals with <italic toggle="yes">GDAP1</italic>-HMSN are often evaluated and managed by a multidisciplinary team that includes neurologists, physiatrists, orthopedic surgeons, and physical and occupational therapists [<xref ref-type="bibr" rid="cmt-4a.REF.corrado.2016.e3278">Corrado et al 2016</xref>, <xref ref-type="bibr" rid="cmt-4a.REF.mccorquodale.2016.7">McCorquodale et al 2016</xref>]. Treatment is symptomatic and may include the following [<xref ref-type="bibr" rid="cmt-4a.REF.mathis.2015.355">Mathis et al [2015]</xref>:</p>
          <list list-type="bullet">
            <list-item>
              <p>Daily heel cord stretching exercises to prevent Achilles tendon shortening.</p>
            </list-item>
            <list-item>
              <p>Exercise within the affected individual's capability</p>
              <p>Note: (1) Fatigue may improve with exercise; (2) unconfirmed anecdotal observations suggest benefit from the stimulant modafinil [<xref ref-type="bibr" rid="cmt-4a.REF.carter.2006.412">Carter et al 2006</xref>, <xref ref-type="bibr" rid="cmt-4a.REF.ramdharry.2012.s208">Ramdharry et al 2012</xref>].</p>
            </list-item>
            <list-item>
              <p>Ankle/foot orthoses (AFOs) to correct foot drop and aid walking [<xref ref-type="bibr" rid="cmt-4a.REF.guillebastre.2011.619">Guillebastre et al 2011</xref>, <xref ref-type="bibr" rid="cmt-4a.REF.phillips.2012.534">Phillips et al 2012</xref>]</p>
            </list-item>
            <list-item>
              <p>Orthopedic surgery to correct severe pes cavus deformity [<xref ref-type="bibr" rid="cmt-4a.REF.boffeli.2015.701">Boffeli &#x00026; Tabatt 2015</xref>, <xref ref-type="bibr" rid="cmt-4a.REF.faldini.2015.e30">Faldini et al 2015</xref>, <xref ref-type="bibr" rid="cmt-4a.REF.ferraro.2017">Ferraro et al 2017</xref>]</p>
            </list-item>
            <list-item>
              <p>Forearm crutches or canes for gait stability</p>
            </list-item>
            <list-item>
              <p>Wheelchair for mobility because of gait instability</p>
            </list-item>
            <list-item>
              <p>Treatment of musculoskeletal pain with acetaminophen or nonsteroidal anti-inflammatory drugs (NSAID) [<xref ref-type="bibr" rid="cmt-4a.REF.kroenke.2009.206">Kroenke et al 2009</xref>]</p>
            </list-item>
            <list-item>
              <p>Treatment of neuropathic pain with tricyclic antidepressants or drugs such as carbamazepine or gabapentin [<xref ref-type="bibr" rid="cmt-4a.REF.shy.2006.255">Shy 2006</xref>, <xref ref-type="bibr" rid="cmt-4a.REF.bril.2011.910">Bril et al 2011</xref>, <xref ref-type="bibr" rid="cmt-4a.REF.ribiere.2012.160">Ribiere et al 2012</xref>, <xref ref-type="bibr" rid="cmt-4a.REF.jeong.2013.397">Jeong et al 2013</xref>]</p>
            </list-item>
            <list-item>
              <p>Weight control to avoid obesity, which has a negative effect on gait and balance</p>
            </list-item>
            <list-item>
              <p>Career and employment counseling because of persistent weakness of hands and/or feet</p>
            </list-item>
            <list-item>
              <p>Individual psychotherapy, group therapy, and/or antidepressant medication for depression [<xref ref-type="bibr" rid="cmt-4a.REF.cordeiro.2014.185">Cordeiro et al 2014</xref>]</p>
            </list-item>
          </list>
          <p>Treatment may require involvement of specialists to evaluate and manage potential complications, including the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Lower urinary tract involvement [<xref ref-type="bibr" rid="cmt-4a.REF.krhut.2014.319">Krhut et al 2014</xref>]</p>
            </list-item>
            <list-item>
              <p>Obstructive sleep apnea and restless legs [<xref ref-type="bibr" rid="cmt-4a.REF.boentert.2014.319">Boentert et al 2014</xref>]</p>
            </list-item>
            <list-item>
              <p>Pulmonary compromise and/or phrenic nerve involvement [<xref ref-type="bibr" rid="cmt-4a.REF.aboussouan.2007.1">Aboussouan et al 2007</xref>]</p>
            </list-item>
            <list-item>
              <p>Vocal cord paresis</p>
            </list-item>
            <list-item>
              <p>Hip dysplasia [<xref ref-type="bibr" rid="cmt-4a.REF.bamford.2009.408">Bamford et al 2009</xref>, <xref ref-type="bibr" rid="cmt-4a.REF.novais.2014.665">Novais et al 2014</xref>]</p>
            </list-item>
          </list>
          <p>Note: No special diet (including supplements with essential fatty acids, vitamin E, or creatine) has been shown to be beneficial [<xref ref-type="bibr" rid="cmt-4a.REF.mathis.2015.355">Mathis et al 2015</xref>].</p>
        </sec>
        <sec id="cmt-4a.Surveillance">
          <title>Surveillance</title>
          <p>Regular evaluations to determine:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic status and need for treatment (or change in treatment) for musculoskeletal and/or neuropathic pain;</p>
            </list-item>
            <list-item>
              <p>Functional disability and need for change in physical therapy regime and/or augmentative devices for activities of daily living and mobility;</p>
            </list-item>
            <list-item>
              <p>Need for change in diet to control weight;</p>
            </list-item>
            <list-item>
              <p>Need to involve specialists to evaluate and treat potential complications.</p>
            </list-item>
          </list>
        </sec>
        <sec id="cmt-4a.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>The following should be avoided:</p>
          <list list-type="bullet">
            <list-item>
              <p>Obesity because of its negative effect on gait and balance</p>
            </list-item>
            <list-item>
              <p>Medications that are toxic or potentially toxic to persons with HMSN (CMT) ranging from definite high risk to negligible risk. Click <inline-supplementary-material xmlns:xlink="http://www.w3.org/1999/xlink" xlink:title="media" xlink:href="cmt_and_medications.pdf" content-type="local-data">here</inline-supplementary-material> (pdf) for an up-to-date list.</p>
            </list-item>
          </list>
        </sec>
        <sec id="cmt-4a.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>It is appropriate to clarify the genetic status of apparently asymptomatic at-risk relatives in order to identify as early as possible those who would benefit from prompt initiation of treatment and knowledge about <xref ref-type="sec" rid="cmt-4a.AgentsCircumstances_to_Avoid">agents/circumstances to avoid</xref>.</p>
          <p>See <xref ref-type="sec" rid="cmt-4a.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="cmt-4a.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p><xref ref-type="bibr" rid="cmt-4a.REF.mathis.2015.355">Mathis et al [2015]</xref> discuss more speculative possible future therapies for HMSN including neurotrophic factors, targeting transport defects, enhancement of autophagy-lysosomal pathways, and neuroregeneration.</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
      </sec>
      <sec id="cmt-4a.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="cmt-4a.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">GDAP1</italic>-related hereditary motor and sensory neuropathy (<italic toggle="yes">GDAP1</italic>-HMSN) is inherited in an autosomal recessive manner (AR <italic toggle="yes">GDAP1</italic>-HMSN) or, less frequently, autosomal dominant manner (AD <italic toggle="yes">GDAP1</italic>-HMSN).</p>
        </sec>
        <sec id="cmt-4a.Risk_to_Family_Members__Autosomal">
          <title>Risk to Family Members &#x02014; Autosomal Recessive Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The parents of a child with AR <italic toggle="yes">GDAP1</italic>-HMSN are obligate heterozygotes for a <italic toggle="yes">GDAP1</italic> pathogenic variant.</p>
            </list-item>
            <list-item>
              <p>Heterozygotes are typically asymptomatic (see <xref ref-type="sec" rid="cmt-4a.Clinical_Description">Clinical Description</xref>).</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At conception, each sib of an affected individual has a 25% chance of being affected, a 50% chance of being heterozygous, and a 25% chance of being unaffected and not heterozygous.</p>
            </list-item>
            <list-item>
              <p>The phenotype is generally consistent among family members with the same genotype; however, intrafamilial variability has been observed in one family with AR <italic toggle="yes">GDAP1</italic>-HMSN [<xref ref-type="bibr" rid="cmt-4a.REF.azzedine.2003.341">Azzedine et al 2003</xref>].</p>
            </list-item>
            <list-item>
              <p>Heterozygotes are typically asymptomatic (see <xref ref-type="sec" rid="cmt-4a.Clinical_Description">Clinical Description</xref>).</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> The offspring of an individual with AR <italic toggle="yes">GDAP1</italic>-HMSN are obligate heterozygotes for a <italic toggle="yes">GDAP1</italic> pathogenic variant and are typically asymptomatic (see <xref ref-type="sec" rid="cmt-4a.Clinical_Description">Clinical Description</xref>).</p>
          <p><bold>Other family members.</bold> Each sib of the proband's parents are at a 50% risk of being heterozygous for a <italic toggle="yes">GDAP1</italic> pathogenic variant.</p>
          <p><bold>Carrier (heterozygote) detection.</bold> Carrier testing for at-risk relatives requires prior identification of the <italic toggle="yes">GDAP1</italic> pathogenic variants in the family.</p>
        </sec>
        <sec id="cmt-4a.Risk_to_Family_Members__Autosomal_1">
          <title>Risk to Family Members &#x02014; Autosomal Dominant Inheritance</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Most individuals diagnosed with AD <italic toggle="yes">GDAP1</italic>-HMSN have an affected parent.</p>
            </list-item>
            <list-item>
              <p>The proportion of cases caused by a <italic toggle="yes">de novo</italic> pathogenic variant is unknown.</p>
            </list-item>
            <list-item>
              <p>Molecular genetic testing of the parents for the <italic toggle="yes">GDAP1</italic> pathogenic variant identified in the proband is recommended.</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">GDAP1</italic> pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, possible explanations include a <italic toggle="yes">de novo</italic> pathogenic variant in the proband or germline mosaicism in a parent (though theoretically possible, no instances of germline mosaicism have been reported).</p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband.</bold> The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents:</p>
          <list list-type="bullet">
            <list-item>
              <p>If a parent of the proband has the <italic toggle="yes">GDAP1</italic> pathogenic variant, the risk to the sibs of inheriting the variant is 50%. Intrafamilial clinical variability and reduced penetrance have been observed [<xref ref-type="bibr" rid="cmt-4a.REF.zimo_.2011.540">Zimo&#x00144; et al 2011</xref>].</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">GDAP1</italic> pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is presumed to be slightly greater than that of the general population (though still &#x0003c;1%) because of the theoretic possibility of parental germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with AD <italic toggle="yes">GDAP1</italic>-HMSN has a 50% chance of inheriting the pathogenic variant.</p>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband's parents: if a parent has the <italic toggle="yes">GDAP1</italic> pathogenic variant, his or her family members may be at risk.</p>
        </sec>
        <sec id="cmt-4a.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="cmt-4a.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</xref> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk, clarification of carrier status, and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected, are carriers, or are at risk of being carriers.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="cmt-4a.Prenatal_Testing_and_Preimplantat">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">GDAP1</italic> pathogenic variant(s) have been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis are possible.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="cmt-4a.Resources">
        <title>Resources</title>
      </sec>
      <sec id="cmt-4a.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">GDAP1</italic> comprises six exons spanning about 14 kb. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cmt-4a" object-id="cmt-4a.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic variants.</bold> To date, more than 80 pathogenic variants have been identified. Known pathogenic variants include deletions, insertions, and nonsense, missense, and splice site variants throughout the gene (see <related-object source-id="gene" document-id="cmt-4a" object-id="cmt-4a.molgen.TA">Table A</related-object>).</p>
        <p>The following variants have been detected in specific populations:</p>
        <list list-type="bullet">
          <list-item>
            <p>p.Gln163Ter in a Hispanic population [<xref ref-type="bibr" rid="cmt-4a.REF.boerkoel.2003.400">Boerkoel et al 2003</xref>]</p>
          </list-item>
          <list-item>
            <p>p.Leu239Phe in central and eastern European populations [<xref ref-type="bibr" rid="cmt-4a.REF.kabzi_ska.2010.357">Kabzi&#x00144;ska et al 2010</xref>]</p>
          </list-item>
        </list>
        <p>Note: A number of <italic toggle="yes">GDAP1</italic> pathogenic variants associated with AD <italic toggle="yes">GDAP1</italic>-HMSN (formerly known as CMT2K) have been described. See <related-object link-type="booklink" source-id="gene" document-id="cmt2" document-type="chapter">CMT2</related-object> [<xref ref-type="bibr" rid="cmt-4a.REF.claramunt.2005.358">Claramunt et al 2005</xref>, <xref ref-type="bibr" rid="cmt-4a.REF.chung.2008.360">Chung et al 2008</xref>, <xref ref-type="bibr" rid="cmt-4a.REF.sahincalapoglu.2009.106">Sahin-Calapoglu et al 2009</xref>].</p>
        <p>The <italic toggle="yes">GDAP1</italic> pathogenic variant, p.Glu222Lys, may be uniquely associated with both AR <italic toggle="yes">GDAP1</italic>-HMSN and (in rare cases) AD <italic toggle="yes">GDAP1</italic>-HMSN [<xref ref-type="bibr" rid="cmt-4a.REF.kabzi_ska.2014.739">Kabzi&#x00144;ska et al 2014</xref>].</p>
        <table-wrap id="cmt-4a.T.selected_gdap1_pathogenic_varia" orientation="portrait" position="anchor">
          <label>Table 3. </label>
          <caption>
            <p>Selected <italic toggle="yes">GDAP1</italic> Pathogenic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_cmt-4a.T.selected_gdap1_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_cmt-4a.T.selected_gdap1_pathogenic_varia_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_cmt-4a.T.selected_gdap1_pathogenic_varia_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_cmt-4a.T.selected_gdap1_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.347T&#x0003e;G</td>
                <td headers="hd_h_cmt-4a.T.selected_gdap1_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Met116Arg</td>
                <td headers="hd_h_cmt-4a.T.selected_gdap1_pathogenic_varia_1_1_1_3" rowspan="6" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/108773796">NM_018972.2</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/108773797">NP_061845.2</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_cmt-4a.T.selected_gdap1_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.358C&#x0003e;T</td>
                <td headers="hd_h_cmt-4a.T.selected_gdap1_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg120Trp</td>
              </tr>
              <tr>
                <td headers="hd_h_cmt-4a.T.selected_gdap1_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.368A&#x0003e;G</td>
                <td headers="hd_h_cmt-4a.T.selected_gdap1_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.His123Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_cmt-4a.T.selected_gdap1_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.469A&#x0003e;C</td>
                <td headers="hd_h_cmt-4a.T.selected_gdap1_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Thr157Pro</td>
              </tr>
              <tr>
                <td headers="hd_h_cmt-4a.T.selected_gdap1_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.487C&#x0003e;T</td>
                <td headers="hd_h_cmt-4a.T.selected_gdap1_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln163Ter</td>
              </tr>
              <tr>
                <td headers="hd_h_cmt-4a.T.selected_gdap1_pathogenic_varia_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.715C&#x0003e;T</td>
                <td headers="hd_h_cmt-4a.T.selected_gdap1_pathogenic_varia_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu239Phe</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the author. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold> The protein ganglioside-induced differentiation-associated protein-1 comprises 358 amino acids. It contains a glutathione-S-transferase (GST) domain and belongs to a new class of GST-like proteins, which have a transmembrane domain in the C-terminal extension [<xref ref-type="bibr" rid="cmt-4a.REF.marco.2004.176">Marco et al 2004</xref>]. <xref ref-type="bibr" rid="cmt-4a.REF.pedrola.2005.1087">Pedrola et al [2005]</xref> investigated a human neuroblastoma cell line that transiently over-expressed GDAP1 and found co-localization with mitochondrial marker proteins. Western blots of subcellular fractions confirmed this finding. They also showed that C-terminal transmembrane domains are necessary for the correct localization in mitochondria; however, missense variants did not change the mitochondrial pattern of the wild-type protein [<xref ref-type="bibr" rid="cmt-4a.REF.pedrola.2005.1087">Pedrola et al 2005</xref>].</p>
        <p><xref ref-type="bibr" rid="cmt-4a.REF.niemann.2005.1067">Niemann et al [2005]</xref> showed that GDAP1 is located in the mitochondrial outer membrane and regulates the mitochondrial network. GDAP1 induces fragmentation (fission) of mitochondria, the opposite function of mitofusin-2, encoded by <italic toggle="yes">MFN2</italic>, pathogenic variants in which cause <related-object link-type="booklink" source-id="gene" document-id="cmt2a" document-type="chapter">CMT2A</related-object>.</p>
        <p><bold>Abnormal gene product.</bold> Loss of ganglioside-induced differentiation-associated protein-1 results in loss of mitochondrial fragmentation activity. Disease-associated missense variants also result in reduced activity [<xref ref-type="bibr" rid="cmt-4a.REF.niemann.2005.1067">Niemann et al 2005</xref>, <xref ref-type="bibr" rid="cmt-4a.REF.pareyson.2015.66">Pareyson et al 2015</xref>]. Pathogenic variants have been reported in all regions of the protein. Variants associated with AR and AD disease include both loss-of-function and missense variants</p>
      </sec>
      <sec id="cmt-4a.References">
        <title>References</title>
        <sec id="cmt-4a.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="cmt-4a.Literature_Cited.reflist0">
            <ref id="cmt-4a.REF.aboussouan.2007.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Aboussouan</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lewis</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shy</surname>
                    <given-names>ME</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Disorders of pulmonary function, sleep, and the upper airway in Charcot-Marie-Tooth disease.</article-title>
                <source>Lung.</source>
                <year>2007</year>
                <volume>185</volume>
                <fpage>1</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">17294338</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.ammar.2003.720">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ammar</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merlini</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barisic</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amouri</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ceuterick</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmerman</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hentati</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Identification of novel GDAP1 mutations causing autosomal recessive Charcot-Marie-Tooth disease.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>13</volume>
                <fpage>720</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">14561495</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.auergrumbach.2008.33">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Auer-Grumbach</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischer</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papi&#x00107;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>John</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plecko</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bittner</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernert</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pieber</surname>
                    <given-names>TR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miltenberger</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwarz</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Windpassinger</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grill</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmerman</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Speicher</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Janecke</surname>
                    <given-names>AR</given-names>
                  </name>
                </person-group>
                <article-title>Two novel mutations in the GDAP1 and PRX genes in early onset Charcot-Marie-Tooth syndrome.</article-title>
                <source>Neuropediatrics.</source>
                <year>2008</year>
                <volume>39</volume>
                <fpage>33</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">18504680</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.azzedine.2003.341">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Azzedine</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruberg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ente</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilardeau</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>P&#x000e9;ri&#x000e9;</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wechsler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LeGuern</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubourg</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <article-title>Variability of disease progression in a family with autosomal recessive CMT associated with a S194X and new R310Q mutation in the GDAP1 gene.</article-title>
                <source>Neuromuscul Disord.</source>
                <year>2003</year>
                <volume>13</volume>
                <fpage>341</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12868504</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.bamford.2009.408">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bamford</surname>
                    <given-names>NS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>KK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robinett</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Otto</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gospe</surname>
                    <given-names>SM</given-names>
                    <suffix>Jr</suffix>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Neuromuscular hip dysplasia in Charcot-Marie-Tooth disease type 1A.</article-title>
                <source>Dev Med Child Neurol.</source>
                <volume>51</volume>
                <fpage>408</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">19388151</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.bar_nkov_.2007.482">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bar&#x000e1;nkov&#x000e1;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vyhn&#x000e1;lkov&#x000e1;</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Z&#x000fc;chner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazanec</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakmaryov&#x000e1;</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vondr&#x000e1;cek</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merlini</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bojar</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seeman</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>GDAP1 mutations in Czech families with early-onset CMT.</article-title>
                <source>Neuromuscul Disord.</source>
                <volume>17</volume>
                <fpage>482</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17433678</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.baxter.2002.21">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baxter</surname>
                    <given-names>RV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben Othmane</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rochelle</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stajich</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hulette</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dew-Knight</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hentati</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ben Hamida</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bel</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stenger</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilbert</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pericak-Vance</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vance</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Ganglioside-induced differentiation-associated protein-1 is mutant in Charcot-Marie-Tooth disease type 4A/8q21.</article-title>
                <source>Nat Genet</source>
                <volume>30</volume>
                <fpage>21</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">11743579</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.birouk.2003.598">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Birouk</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azzedine</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubourg</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muriel</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benomar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamadouche</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maisonobe</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ouazzani</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brice</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yahyaoui</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chkili</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Guern</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Phenotypical features of a Moroccan family with autosomal recessive Charcot-Marie-Tooth disease associated with the S194X mutation in the GDAP1 gene.</article-title>
                <source>Arch Neurol</source>
                <volume>60</volume>
                <fpage>598</fpage>
                <lpage>604</lpage>
                <pub-id pub-id-type="pmid">12707075</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.boentert.2014.319">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boentert</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knop</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schuhmacher</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gess</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okegwo</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Sleep disorders in Charcot-Marie-Tooth disease type 1.</article-title>
                <source>J Neurol Neurosurg Psychiatry.</source>
                <volume>85</volume>
                <fpage>319</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">23704315</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.boerkoel.2003.400">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boerkoel</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takashima</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakagawa</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Izumo</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Armstrong</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Butler</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancias</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papasozomenos</surname>
                    <given-names>SC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stern</surname>
                    <given-names>LZ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>CMT4A: identification of a Hispanic GDAP1 founder mutation.</article-title>
                <source>Ann Neurol</source>
                <volume>53</volume>
                <fpage>400</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">12601710</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.boffeli.2015.701">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Boffeli</surname>
                    <given-names>TJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tabatt</surname>
                    <given-names>JA</given-names>
                  </name>
                </person-group>
                <article-title>Minimally invasive early operative treatment of progressive foot and ankle deformity associated with Charcot-Marie-Tooth disease.</article-title>
                <source>J Foot Ankle Surg.</source>
                <year>2015</year>
                <volume>54</volume>
                <fpage>701</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">25131389</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.bouhouche.2007.1062">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bouhouche</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Birouk</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Azzedine</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benomar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durosier</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ente</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muriel</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruberg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slassi</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yahyaoui</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dubourg</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ouazzani</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LeGuern</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Autosomal recessive axonal Charcot-Marie-Tooth disease (ARCMT2): phenotype-genotype correlations in 13 Moroccan families.</article-title>
                <source>Brain.</source>
                <year>2007</year>
                <volume>130</volume>
                <fpage>1062</fpage>
                <lpage>75</lpage>
                <pub-id pub-id-type="pmid">17347251</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.bril.2011.910">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bril</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>England</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Franklin</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Backonja</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Del Toro</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Feldman</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iverson</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perkins</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Russell</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zochodne</surname>
                    <given-names>DW</given-names>
                  </name>
                  <etal/>
                </person-group>
                <article-title>Evidence-based guideline: treatment of painful diabetic neuropathy--report of the American Association of Neuromuscular and Electrodiagnostic Medicine, the American Academy of Neurology, and the American Academy of Physical Medicine &#x00026; Rehabilitation.</article-title>
                <source>Muscle Nerve.</source>
                <year>2011</year>
                <volume>43</volume>
                <fpage>910</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">21484835</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.carter.2006.412">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>GT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Han</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayadev</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weiss</surname>
                    <given-names>MD</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Modafinil reduces fatigue in Charcot-Marie-Tooth disease type 1A: a case series.</article-title>
                <source>Am J Hosp Palliat Care</source>
                <volume>23</volume>
                <fpage>412</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">17060310</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.cassereau.2011.1524">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cassereau</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Casasnovas</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gueguen</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malinge</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guillet</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reynier</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonneau</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amati-Bonneau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Banchs</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Volpini</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Procaccio</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chevrollier</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Simultaneous MFN2 and GDAP1 mutations cause major mitochondrial defects in a patient with CMT.</article-title>
                <source>Neurology.</source>
                <volume>76</volume>
                <fpage>1524</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">21519004</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.chung.2008.360">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chung</surname>
                    <given-names>KW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sunwoo</surname>
                    <given-names>IN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cho</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hwang</surname>
                    <given-names>SJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kang</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Park</surname>
                    <given-names>KD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>KG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>IS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Choi</surname>
                    <given-names>BO</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>A novel GDAP1 Q218E mutation in autosomal dominant Charcot-Marie-Tooth disease.</article-title>
                <source>J Hum Genet.</source>
                <volume>53</volume>
                <fpage>360</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">18231710</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.claramunt.2005.358">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Claramunt</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedrola</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sevilla</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez de Munain</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berciano</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cuesta</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanchez-Navarro</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Millan</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saifi</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lupski</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilchez</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Espinos</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palau</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Genetics of Charcot-Marie-Tooth disease type 4A: mutations, inheritance, phenotypic variability, and founder effect.</article-title>
                <source>J Med Genet</source>
                <volume>42</volume>
                <fpage>358</fpage>
                <lpage>65</lpage>
                <pub-id pub-id-type="pmid">15805163</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.cordeiro.2014.185">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cordeiro</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marques</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hallak</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Os&#x000f3;rio</surname>
                    <given-names>FL</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Charcot-Marie-Tooth disease, psychiatric indicators and quality of life: a systematic review.</article-title>
                <source>ASN Neuro</source>
                <volume>6</volume>
                <fpage>185</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">24654889</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.corrado.2016.e3278">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Corrado</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ciardi</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bargigli</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>Rehabilitation Management of the Charcot-Marie-Tooth Syndrome: A Systematic Review of the Literature.</article-title>
                <source>Medicine (Baltimore)</source>
                <volume>95</volume>
                <fpage>e3278</fpage>
                <pub-id pub-id-type="pmid">27124017</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.cuesta.2002.22">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cuesta</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedrola</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sevilla</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garcia-Planells</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chumillas</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayordomo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>LeGuern</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marin</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilchez</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palau</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>The gene encoding ganglioside-induced differentiation-associated protein 1 is mutated in axonal Charcot-Marie-Tooth type 4A disease.</article-title>
                <source>Nat Genet</source>
                <volume>30</volume>
                <fpage>22</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">11743580</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.de_sandregiovannoli.2003.e87">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Sandre-Giovannoli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chaouch</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boccaccio</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernard</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delague</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grid</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vallat</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levy</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Megarbane</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Phenotypic and genetic exploration of severe demyelinating and secondary axonal neuropathies resulting from GDAP1 nonsense and splicing mutations.</article-title>
                <source>J Med Genet</source>
                <volume>40</volume>
                <fpage>e87</fpage>
                <pub-id pub-id-type="pmid">12843336</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.faldini.2015.e30">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Faldini</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traina</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nanni</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazzotti</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calamelli</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fabbri</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pungetti</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giannini</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Surgical treatment of cavus foot in Charcot-Marie-tooth disease: a review of twenty-four cases: AAOS exhibit selection.</article-title>
                <source>J Bone Joint Surg Am.</source>
                <volume>97</volume>
                <fpage>e30</fpage>
                <pub-id pub-id-type="pmid">25788311</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.ferraro.2017">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ferraro</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dusina</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carantini</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strambi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Galante</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gaiani</surname>
                    <given-names>L.</given-names>
                  </name>
                </person-group>
                <article-title>A case series study on the efficacy of functional surgery associated with early intensive rehabilitation therapy in Charcot-Marie-Tooth type 1A disease.</article-title>
                <source>Eur J Phys Rehabil Med.</source>
                <year>2017</year>
                <month>Mar</month>
                <day>6</day>
                <comment>Epub ahead of print</comment>
                <pub-id pub-id-type="pmid">28264542</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.guillebastre.2011.619">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Guillebastre</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calmels</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rougier</surname>
                    <given-names>PR</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Assessment of appropriate ankle-foot orthoses models for patients with Charcot-Marie-Tooth disease.</article-title>
                <source>Am J Phys Med Rehabil.</source>
                <volume>90</volume>
                <fpage>619</fpage>
                <lpage>27</lpage>
                <pub-id pub-id-type="pmid">21681059</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.jeong.2013.397">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jeong</surname>
                    <given-names>NY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shin</surname>
                    <given-names>YH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jung</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Neuropathic pain in hereditary peripheral neuropathy.</article-title>
                <source>J Exerc Rehabil</source>
                <volume>9</volume>
                <fpage>397</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">24278891</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.kabzi_ska.2014.739">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kabzi&#x00144;ska</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kotruchow</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cegielska</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hausmanowa-Petrusewicz</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kocha&#x00144;ski</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>A severe recessive and a mild dominant form of Charcot-Marie-Tooth disease associated with a newly identified Glu222Lys GDAP1 gene mutation.</article-title>
                <source>Acta Biochim Pol.</source>
                <volume>61</volume>
                <fpage>739</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">25337607</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.kabzi_ska.2010.357">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kabzi&#x00144;ska</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Strugalska-Cynowska</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kostera-Pruszczyk</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ryniewicz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Posmyk</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Midro</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seeman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>B&#x000e1;rankov&#x000e1;</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zimo&#x00144;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baets</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmerman</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guergueltcheva</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournev</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sarafov</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jordanova</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hausmanowa-Petrusewicz</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kocha&#x00144;ski</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>L239F founder mutation in GDAP1 is associated with a mild Charcot-Marie-Tooth type 4C4 (CMT4C4) phenotype.</article-title>
                <source>Neurogenetics.</source>
                <volume>11</volume>
                <fpage>357</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">20232219</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.kennedy.2016.317">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kennedy</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carroll</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McGinley</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>Gait in children and adolescents with Charcot-Marie-Tooth disease: a systematic review.</article-title>
                <source>J Peripher Nerv Syst.</source>
                <volume>21</volume>
                <fpage>317</fpage>
                <lpage>28</lpage>
                <pub-id pub-id-type="pmid">27513454</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.kosterapruszczyk.2014.242">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kostera-Pruszczyk</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kosinska</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pollak</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stawinski</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Walczak</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wasilewska</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Potulska-Chromik</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Szczudlik</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaminska</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ploski</surname>
                    <given-names>R</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Exome sequencing reveals mutations in MFN2 and GDAP1 in severe Charcot-Marie-Tooth disease.</article-title>
                <source>J Peripher Nerv Syst.</source>
                <volume>19</volume>
                <fpage>242</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">25403865</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.krhut.2014.319">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Krhut</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mazanec</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Seeman</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mann-Gow</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zvara</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>Lower urinary tract functions in a series of Charcot-Marie-Tooth neuropathy patients.</article-title>
                <source>Acta Neurol Scand.</source>
                <year>2014</year>
                <volume>129</volume>
                <fpage>319</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">23937377</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.kroenke.2009.206">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kroenke</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krebs</surname>
                    <given-names>EE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bair</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Pharmacotherapy of chronic pain: a synthesis of recommendations from systematic reviews.</article-title>
                <source>Gen Hosp Psychiatry.</source>
                <volume>31</volume>
                <fpage>206</fpage>
                <lpage>19</lpage>
                <pub-id pub-id-type="pmid">19410099</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.manganelli.2014.292">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Manganelli</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tozza</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pisciotta</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellone</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iodice</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nolano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Geroldi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Capponi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mandich</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santoro</surname>
                    <given-names>L.</given-names>
                  </name>
                </person-group>
                <article-title>Charcot-Marie-Tooth disease: frequency of genetic subtypes in a Southern Italy population.</article-title>
                <source>J Peripher Nerv Syst.</source>
                <year>2014</year>
                <volume>19</volume>
                <fpage>292</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">25429913</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.marco.2004.176">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marco</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cuesta</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedrola</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palau</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marin</surname>
                    <given-names>I</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Evolutionary and structural analyses of GDAP1, involved in Charcot-Marie-Tooth disease, characterize a novel class of glutathione transferase-related genes.</article-title>
                <source>Mol Biol Evol</source>
                <volume>21</volume>
                <fpage>176</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">14595091</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.mathis.2015.355">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mathis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magy</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vallat</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Therapeutic options in Charcot-Marie-Tooth diseases.</article-title>
                <source>Expert Rev Neurother.</source>
                <volume>15</volume>
                <fpage>355</fpage>
                <lpage>66</lpage>
                <pub-id pub-id-type="pmid">25703094</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.mccorquodale.2016.7">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>McCorquodale</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pucillo</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>NE</given-names>
                  </name>
                </person-group>
                <year>2016</year>
                <article-title>Management of Charcot-Marie-Tooth disease: improving long-term care with a multidisciplinary approach.</article-title>
                <source>J Multidiscip Healthc.</source>
                <volume>9</volume>
                <fpage>7</fpage>
                <lpage>19</lpage>
                <pub-id pub-id-type="pmid">26855581</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.nelis.2002.1865">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nelis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erdem</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Den Bergh</surname>
                    <given-names>PY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belpaire-Dethiou</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ceuterick</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Gerwen</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cuesta</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedrola</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palau</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gabreels-Festen</surname>
                    <given-names>AA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verellen</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Demirci</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Broeckhoven</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topaloglu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmerman</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Mutations in GDAP1: autosomal recessive CMT with demyelination and axonopathy.</article-title>
                <source>Neurology</source>
                <volume>59</volume>
                <fpage>1865</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">12499475</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.niemann.2005.1067">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Niemann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruegg</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>La Padula</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schenone</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suter</surname>
                    <given-names>U</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Ganglioside-induced differentiation associated protein 1 is a regulator of the mitochondrial network: new implications for Charcot-Marie-Tooth disease.</article-title>
                <source>J Cell Biol</source>
                <volume>170</volume>
                <fpage>1067</fpage>
                <lpage>78</lpage>
                <pub-id pub-id-type="pmid">16172208</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.novais.2014.665">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Novais</surname>
                    <given-names>EN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bixby</surname>
                    <given-names>SD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rennick</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carry</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kim</surname>
                    <given-names>YJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Millis</surname>
                    <given-names>MB</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Hip dysplasia is more severe in Charcot-Marie-Tooth disease than in developmental dysplasia of the hip.</article-title>
                <source>Clin Orthop Relat Res.</source>
                <volume>472</volume>
                <fpage>665</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">23943527</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.pareyson.2015.66">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pareyson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saveri</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sagnelli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piscosquito</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <article-title>Mitochondrial dynamics and inherited peripheral nerve diseases.</article-title>
                <source>Neurosci Lett.</source>
                <year>2015</year>
                <volume>596</volume>
                <fpage>66</fpage>
                <lpage>77</lpage>
                <pub-id pub-id-type="pmid">25847151</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.pedrola.2005.1087">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pedrola</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Espert</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claramunt</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shy</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palau</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>GDAP1, the protein causing Charcot-Marie-Tooth disease type 4A, is expressed in neurons and is associated with mitochondria.</article-title>
                <source>Hum Mol Genet</source>
                <volume>14</volume>
                <fpage>1087</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">15772096</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.phillips.2012.534">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Phillips</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robertson</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Killen</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>White</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>A pilot study of a crossover trial with randomized use of ankle-foot orthoses for people with Charcot-Marie-tooth disease.</article-title>
                <source>Clin Rehabil.</source>
                <year>2012</year>
                <volume>26</volume>
                <fpage>534</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">22089961</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.ramdharry.2012.s208">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ramdharry</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thornhill</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mein</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reilly</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marsden</surname>
                    <given-names>JF</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Exploring the experience of fatigue in people with Charcot-Marie-Tooth disease.</article-title>
                <source>Neuromuscul Disord.</source>
                <volume>22</volume>
                <supplement>Suppl 3</supplement>
                <fpage>S208</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">23182641</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.ribiere.2012.160">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ribiere</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernardin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sacconi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delmont</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fournier-Mehouas</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rauscent</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benchortane</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Staccini</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lant&#x000e9;ri-Minet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desnuelle</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Pain assessment in Charcot-Marie-Tooth (CMT) disease.</article-title>
                <source>Ann Phys Rehabil Med.</source>
                <volume>55</volume>
                <fpage>160</fpage>
                <lpage>73</lpage>
                <pub-id pub-id-type="pmid">22475878</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.rudniksch_neborn.2016.34">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rudnik-Sch&#x000f6;neborn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>T&#x000f6;lle</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senderek</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eggermann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elbracht</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kornak</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von der Hagen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kirschner</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leube</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>M&#x000fc;ller-Felber</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schara</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>von Au</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wieczorek</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bu&#x000df;mann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zerres</surname>
                    <given-names>K.</given-names>
                  </name>
                </person-group>
                <article-title>Diagnostic algorithms in Charcot-Marie-Tooth neuropathies: experiences from a German genetic laboratory on the basis of 1206 index patients.</article-title>
                <source>Clin Genet.</source>
                <year>2016</year>
                <volume>89</volume>
                <fpage>34</fpage>
                <lpage>43</lpage>
                <pub-id pub-id-type="pmid">25850958</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.sahincalapoglu.2009.106">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sahin-Calapoglu</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soyoz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calapoglu</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozcelik</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Novel GDAP1 mutation in a Turkish family with CMT2K (CMT2K with novel GDAP1 mutation).</article-title>
                <source>Neuromolecular Med.</source>
                <volume>11</volume>
                <fpage>106</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">19381883</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.senderek.2003.642">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Senderek</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bergmann</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ramaekers</surname>
                    <given-names>VT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelis</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bernert</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Makowski</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Z&#x000fc;chner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudnik-Schoneborn</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zerres</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schroder</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Mutations in the ganglioside-induced differentiation-associated protein-1 (GDAP1) gene in intermediate type autosomal recessive Charcot-Marie-Tooth neuropathy.</article-title>
                <source>Brain</source>
                <volume>126</volume>
                <fpage>642</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12566285</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.sevilla.2003.2023">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sevilla</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cuesta</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chumillas</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayordomo</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedrola</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palau</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilchez</surname>
                    <given-names>JJ</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Clinical, electrophysiological and morphological findings of Charcot-Marie-Tooth neuropathy with vocal cord palsy and mutations in the GDAP1 gene.</article-title>
                <source>Brain</source>
                <volume>126</volume>
                <fpage>2023</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">12821518</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.sevilla.2008.3051">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sevilla</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaijo</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nauffal</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collado</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chumillas</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vilchez</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muelas</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bataller</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Domenech</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Espin&#x000f3;s</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Palau</surname>
                    <given-names>F</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Vocal cord paresis and diaphragmatic dysfunction are severe and frequent symptoms of GDAP1-associated neuropathy.</article-title>
                <source>Brain</source>
                <volume>131</volume>
                <fpage>3051</fpage>
                <lpage>61</lpage>
                <pub-id pub-id-type="pmid">18812441</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.shy.2006.255">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shy</surname>
                    <given-names>ME</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Therapeutic Strategies for the Inherited Neuropathies.</article-title>
                <source>Neuromolecular Med.</source>
                <year>2006</year>
                <volume>8</volume>
                <fpage>255</fpage>
                <lpage>78</lpage>
                <pub-id pub-id-type="pmid">16775380</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.stojkovic.2004.261">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stojkovic</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latour</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viet</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Seze</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hurtevent</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vandenberghe</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermersch</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Vocal cord and diaphragm paralysis, as clinical features of a French family with autosomal recessive Charcot-Marie-Tooth disease, associated with a new mutation in the GDAP1 gene.</article-title>
                <source>Neuromuscul Disord</source>
                <volume>14</volume>
                <fpage>261</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">15019704</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.vital.2012.735">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vital</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Latour</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sole</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrer</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouanet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tison</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vital</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goizet</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>A French family with Charcot-Marie-Tooth disease related to simultaneous heterozygous MFN2 and GDAP1 mutations.</article-title>
                <source>Neuromuscul Disord.</source>
                <volume>22</volume>
                <fpage>735</fpage>
                <lpage>41</lpage>
                <pub-id pub-id-type="pmid">22546700</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.yoshimura.2017">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yoshimura</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yuan</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hashiguchi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hiramatsu</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ando</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Higuchi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okamoto</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumura</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamano</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sawaura</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimatani</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumada</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okumura</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyahara</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamaguchi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kitamura</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haginoya</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mitsui</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ishiura</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takashima</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <article-title>Clinical and mutational spectrum of Japanese patients with Charcot-Marie-Tooth disease caused by GDAP1 variants.</article-title>
                <source>Clin Genet.</source>
                <year>2017</year>
                <month>Feb</month>
                <day>28</day>
                <comment>Epub ahead of print</comment>
                <pub-id pub-id-type="pmid">28244113</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.zimo_.2011.540">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zimo&#x00144;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baets</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fabrizi</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jaakkola</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kabzi&#x00144;ska</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pilch</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schindler</surname>
                    <given-names>AB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cornblath</surname>
                    <given-names>DR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fischbeck</surname>
                    <given-names>KH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Auer-Grumbach</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guelly</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huber</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vriendt</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmerman</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suter</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hausmanowa-Petrusewicz</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niemann</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kocha&#x00144;ski</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jordanova</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>Dominant GDAP1 mutations cause predominantly mild CMT phenotypes.</article-title>
                <source>Neurology</source>
                <volume>77</volume>
                <fpage>540</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">21753178</pub-id>
              </element-citation>
            </ref>
            <ref id="cmt-4a.REF.zimo_.2015.33">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zimo&#x00144;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Battalo&#x0011f;lu</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parman</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Erdem</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baets</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Vriendt</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atkinson</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Almeida-Souza</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deconinck</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ozes</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goossens</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cirak</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Damme</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shboul</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voit</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Maldergem</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dan</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El-Khateeb</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guergueltcheva</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lopez-Laso</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goemans</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masri</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Z&#x000fc;chner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmerman</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Topalo&#x0011f;lu</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jordanova</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Unraveling the genetic landscape of autosomal recessive Charcot-Marie-Tooth neuropathies using a homozygosity mapping approach.</article-title>
                <source>Neurogenetics</source>
                <volume>16</volume>
                <fpage>33</fpage>
                <lpage>42</lpage>
                <pub-id pub-id-type="pmid">25231362</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="cmt-4a.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="cmt-4a.Author_History">
          <title>Author History</title>
          <p>Thomas D Bird, MD (2017-present)Jeffery M Vance, MD, PhD; University of Miami (2004-2017)Stephan Z&#x000fc;chner, MD; University of Miami (2004-2017)</p>
        </sec>
        <sec id="cmt-4a.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>30 March 2017 (bp) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>28 February 2013 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>3 June 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>6 March 2007 (jv) Revision: prenatal testing available</p>
            </list-item>
            <list-item>
              <p>23 June 2006 (ca) Comprehensive update posted to live Web site</p>
            </list-item>
            <list-item>
              <p>11 May 2004 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>23 February 2004 (jv,sz) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
